Posted by
erlotinib (Tarceva)

erlotinib (Tarceva)

What is erlotinib, and how does it work (mechanism of action)? Erlotinib is a synthetic (man-made) oral drug that is used for treating cancer. It is approved for treatment of non-small cell lung cancer (NSCLC). There are more than 1.2 million cases worldwide of lung cancer each year, causing one death every 3 seconds. According […]

Posted by
Justice Ruth Bader Ginsburg Treated for Pancreatic Cancer

Justice Ruth Bader Ginsburg Treated for Pancreatic Cancer

Latest Cancer News FRIDAY, Aug. 23, 2019 (HealthDay News) — Justice Ruth Bader Ginsburg has just finished treatment for pancreatic cancer, the U.S. Supreme Court announced Friday. After the tumor was first diagnosed in late July, Ginsburg was given a three-week course of focused radiation at Memorial Sloan Kettering Cancer Center in New York City, […]

Posted by
aldesleukin (Proleukin)

aldesleukin (Proleukin)

What is aldesleukin, and how does it work (mechanism of action)? Aldesleukin is a man-made protein that has the same action as native human interleukin-2 (IL-2) that is used for treating cancer of the kidney and skin. Interleukins are the messengers by which white blood cells communicate with each other to coordinate inflammation and immunity. […]

Posted by
docetaxel (Taxotere, Docefrez)

docetaxel (Taxotere, Docefrez)

What is docetaxel, and how does it work (mechanism of action)? Docetaxel is a drug that is used primarily for treating breast cancer. Docetaxel works by attacking cancer cells. Every cell in the body contains a supporting structure (almost like a skeleton) called the microtubular network. If this “skeleton” is changed or damaged, the cell […]

Posted by
sargramostim (Leukine)

sargramostim (Leukine)

What is sargramostim, and how does it work (mechanism of action)? Sargramostim is a man-made form of the naturally-occurring protein, granulocyte, macrophage-colony stimulating factor (GM-CSF). GM-CSF is produced in the body by the immune system and stimulates the formation of white blood cells, including the granulocyte and the macrophage. Granulocytes and macrophages take part in […]

Posted by
U.S. Task Force Updates Breast Cancer Gene Testing Recommendations

U.S. Task Force Updates Breast Cancer Gene Testing Recommendations

By Serena GordonHealthDay Reporter Latest Cancer News TUESDAY, Aug. 20, 2019 (HealthDay News) — Mutations in two genes — BRCA1 and BRCA2 — are known to significantly increase the risk of breast cancer, but experts have long debated which women should be tested for them. New recommendations from the U.S. Preventive Services Task Force (USPSTF) […]

Posted by
Rozlytrek Approved to Treat Tumors With <i>NTRK</i> Gene Fusion

Rozlytrek Approved to Treat Tumors With NTRK Gene Fusion

<img class="healthday_image" src="https://www.medicationjunction.com/wp-content/uploads/2019/08/rozlytrek-approved-to-treat-tumors-with-ntrk-gene-fusion.jpg" alt="News Picture: Rozlytrek Approved to Treat Tumors With NTRK Gene Fusion”> Latest Cancer News MONDAY, Aug. 19, 2019 (HealthDay News) — Rozlytrek (entrectinib), a kinase inhibitor, has received approval to treat adults and adolescents with cancer that carries the genetic defect neurotrophic tyrosine receptor kinase (NTRK) gene fusion and has progressed following […]

Posted by
FDA Approves Inrebic Capsules for Myelofibrosis

FDA Approves Inrebic Capsules for Myelofibrosis

Latest Cancer News FRIDAY, Aug. 16, 2019 (HealthDay News) — Inrebic (fedratinib) capsules have been approved to treat adults with intermediate-2 or high-risk primary or secondary myelofibrosis, making it the second drug approved to treat patients with this disease, the U.S. Food and Drug Administration announced today. Approval of Inrebic for patients with intermediate-2 or […]

Posted by
imatinib (Gleevec)

imatinib (Gleevec)

What is imatinib, and how does it work (mechanism of action)? Imatinib is an oral medication used for treating chronic myeloid leukemia and acute lymphoblastic leukemia. It is classified as a kinase inhibitor. Kinase inhibitors include dasatinib (Sprycel), erlotinib (Tarceva), gefitinib (Iressa), nilotinib (Tasigna), pazopanib (Votrient), sunitinib (Sutent), and vandetanib (Caprelsa). Kinase inhibitors prevent tumors […]

Posted by
America&#8217;s Obesity Epidemic May Mean Some Cancers Are Striking Sooner

America’s Obesity Epidemic May Mean Some Cancers Are Striking Sooner

By Alan MozesHealthDay Reporter Latest Cancer News WEDNESDAY, Aug. 14, 2019 (HealthDay News) — Since the turn of the century, American obesity rates have skyrocketed. And now a new study indicates that as the nation’s waistlines expand, cancers long linked to obesity are striking the middle-aged more than ever before. The finding follows a review […]